Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2005) 9 P18

BES2005 Poster Presentations Diabetes and metabolism (35 abstracts)

Murine expression of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) and hexose-6-phosphate dehydrogenase (H6PDH)

KN Hewitt , IJ Bujalska , N Draper , CU Onyimba , EA Walker & PM Stewart


Department of Medicine, University of Birmingham, Birmingham, UK.


In humans, glucocorticoids (GC) are implicated in the pathogenesis of obesity and insulin resistance. GCs are regulated at the prereceptor level by 11beta-HSDs. 11beta-HSD1 predominately displays oxo-reductase activity (cortisone/11-dehydrocorticosterone to cortisol/ corticosterone), requiring the cofactor NADPH. Recently, studies in humans have shown that the enzyme H6PDH, by generating NAPDH in the endoplasmic reticulum (ER) is crucial for oxo-reductase activity. This study aimed to determine if these enzymes were coexpressed in metabolic tissues in mice. Liver, muscle and adipose tissue were collected from adult male C57BL/6 mice (n=3). Four adipose depots were collected; gonadal, subcutaneous, perirenal and brown adipose tissue (BAT). Real time PCR was used to quantitate expression of 11beta-HSD1 and H6PDH. All tissues expressed 11beta-HSD1, with the highest levels present in liver and perirenal adipose tissue. H6PDH was also expressed in all depots, with a 4 fold higher expression in perirenal depot compared with other depots. Set point of 11beta-HSD1 activity was assessed in cultured preadipocytes (perirenal, subcutaneous, BAT, gonadal), and myocytes. Oxo-reductase activity was predominant in all tissues. Highest levels of oxo-reductase were in perirenal preadipocytes, 65.9 ± 8.6%; then subcutaneous preadipocytes, 60.8 ± 0.9%, BAT had 54 ± 1.16%, myocytes had 52 ± 4.35% and lowest levels were in gonadal preadipocytes, 45 ± 1.5%. Lower levels of dehydrogenase activity were observed, ranging from 8.1 ± 0.98% in perirenal preadipocytes, 8 ± 0.5% in subcutaneous preadipocytes, 8 ± 0.76% in BAT, 10.14 ± 0.34% in myocytes and highest activity was in gonadal preadipocytes, 20 ± 0.05%. All tissues examined, expressed high levels of both genes. Additionally, cultured preadipocytes and myocytes demonstrated predominant 11beta-HSD1 oxo-reductase activity, and correlated with increased expression of H6PDH. This interaction between H6PDH and 11beta-HSD1 in key metabolic tissues such as liver, fat and muscle is likely to play an important role in insulin sensitivity/obesity.

Volume 9

24th Joint Meeting of the British Endocrine Societies

British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.